Yoshihiro Akazai

Mesorectal Excision With or Without Lateral Lymph Node Dissection for Clinical Stage II/III Lower Rectal Cancer (JCOG0212)

Shin Fujita, Junki Mizusawa, Yukihide Kanemitsu et al. · Annals of Surgery · 2017 · 446 citations · Full text

Medicine, Oncology, Surgery +16

Male sexual dysfunction after rectal cancer surgery: Results of a randomized trial comparing mesorectal excision with and without lateral lymph node dissection for patients with lower rectal cancer: Japan Clinical Oncology Group Study JCOG0212

S. Saito, S. Fujita, Junki Mizusawa et al. · European Journal of Surgical Oncology · 2016 · 138 citations

Medicine, Oncology, Surgery +16

Urinary dysfunction after rectal cancer surgery: Results from a randomized trial comparing mesorectal excision with and without lateral lymph node dissection for clinical stage II or III lower rectal cancer (Japan Clinical Oncology Group Study, JCOG0212)

Masaaki Ito, Akihiro Kobayashi, Shin Fujita et al. · European Journal of Surgical Oncology · 2018 · 129 citations

Medicine, Oncology, Surgery +14

Long-term follow-up of the randomized trial of mesorectal excision with or without lateral lymph node dissection in rectal cancer (JCOG0212)

Shunsuke Tsukamoto, S. Fujita, Masayuki Ota et al. · British journal of surgery · 2020 · 111 citations · Full text

Medicine, Oncology, Surgery +16

Predictive factors of pathological lateral pelvic lymph node metastasis in patients without clinical lateral pelvic lymph node metastasis (clinical stage II/III): The analysis of data from the clinical trial (JCOG0212)

Koji Komori, Shin Fujita, Junki Mizusawa et al. · European Journal of Surgical Oncology · 2018 · 48 citations

Medicine, Oncology, Surgery +16